Consider an expert is assigned to screen a public health important disease which is highly sensitive in one district Which one of the following is the criterion to prioritize the diseases for screening? a. There should be definitive treatment for the disease b. The disease should be less communicable C. Subsequent evaluation of positives has minimal risk d. Subsequent evaluation of positives should be costly

The correct answer is c. Subsequent evaluation of positives has minimal risk.<br /><br />When prioritizing diseases for screening, it is important to consider the potential risks associated with subsequent evaluation of positive cases. If the subsequent evaluation of positives has minimal risk, it means that the screening process can be conducted safely and effectively without causing significant harm or inconvenience to the individuals being screened. This criterion is crucial in ensuring the success and effectiveness of the screening program.<br /><br />Option a, 'There should be definitive treatment for the disease,' is not a criterion for prioritizing diseases for screening. While having a definitive treatment for the disease is important, it is not a primary factor in determining the priority for screening. The availability of treatment should not be the sole determinant for screening, as it may not always be possible to have a definitive treatment for every disease.<br /><br />Option b, 'The disease should be less communicable,' is not a criterion for prioritizing diseases for screening. In fact, highly communicable diseases are often prioritized for screening, as they can spread rapidly and affect a large number of individuals in the population. Screening for highly communicable diseases can help identify and isolate infected individuals, preventing further transmission and protecting public health.<br /><br />Option d, 'Subsequent evaluation of positives should be costly,' is not a criterion for prioritizing diseases for screening. The cost of subsequent evaluation of positives should not be a primary factor in determining the priority for screening. Instead, the focus should be on ensuring the safety and effectiveness of the screening process, as well as the availability of appropriate treatment and follow-up care for positive cases.